Biontech SE
XETRA:22UA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Biontech SE (22UA) under the Base Case is EUR per share.
Compared with the current market price of 75 EUR, the stock appears .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years.
Create a free account · No card needed
Fundamental Analysis
What Biontech Does
BioNTech is a biotechnology company that develops mRNA-based medicines, especially vaccines and cancer treatments. Its best-known product was the COVID-19 vaccine it co-developed with Pfizer, but the company’s main business is broader: it builds drug candidates that teach the body’s immune system to recognize viruses and tumors. It sells approved products where it has them, and it also earns money from partnerships, development payments, and shared profits with larger drug companies.
- Headquarters
- Germany DE
- Employees
- 7 807
- IPO date
- Oct 10, 2019
Biontech has no economic moat
Patients and health systems can choose other COVID-19 vaccines without costly lock-in, and Comirnaty does not become more valuable just because more people use it. BioNTech’s oncology medicines are still in development, while its vaccine and cancer-treatment markets have other suppliers, so the company has no current barrier that reliably keeps competitors from winning customers.
Read the full moat analysisBalance Sheet
Recent Events
Latest Earnings Call
BioNTech raised the midpoint of its 2026 revenue outlook after Q3 and highlighted advancing oncology programs, while reiterating mRNA’s role in its strategy.
Open the earnings call- EPS
- $1.94
- Expected
- $0.85
- Surprise
- +128.2%
- Stock, day of the call
- −0.7%
Biontech insiders are selling more than usual
Insiders sell for many reasons, such as taxes or planned sales; purchases are rarer.
Past 12 months
Continue 22UA Research
Decided on Biontech? Get an email when 22UA reaches the price you’d buy at. Free with an account.
Other Biontech listings
What is the Intrinsic Value of one 22UA stock?
The intrinsic value for
Biontech SE (22UA) under the Base Case is EUR.
Is 22UA stock undervalued or overvalued?
Compared with the current market price of 75 EUR, the stock appears .